COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement

- Furlong, Eliska, Kotecha, Rishi S., Phillips, Marianne B., Padhye, Bhavna, Dalla-Pozza, Luciano, Alvaro, Frank, Fraser, Christopher J., Nicholls, Wayne, Clark, Julia E., O'Connor, Matthew, Saxon, Benjamin R., Tapp, Heather, Conyers, Rachel, Heath, John, Hunter, SE, Tsui, K, Winstanley, M, Lyver, A, Best, EJ, Wadia, U, Yeoh, D, Blyth, CC, Gottardo, NG, O'Brien, Tracey A., Hansford, Jordan R., Super, Leanne, Downie, Peter, Eisenstat, David D., Haeusler, Gabrielle, McMullan, Brendan

Diagnostic yield of initial and consecutive blood cultures in children with cancer and febrile neutropenia

- Haeusler, Gabrielle M., De Abreu Lourenco, Richard, Clark, Hannah, Thursky, Karin A., Slavin, Monica A., Babl, Franz E., Mechinaud, Francoise, Alvaro, Frank, Clark, Julia, Padhye, Bhavna, Phillips, Marianne, Super, Leanne, Tapp, Heather, Walwyn, Thomas, Ziegler, David, Phillips, Robert, Worth, Leon J.

Examining health-related quality of life in pediatric cancer patients with febrile neutropenia: Factors predicting poor recovery in children and their parents

- Crothers, Anna, Haeusler, Gabrielle M., Walwyn, Thomas, Super, Leanne, Alvaro, Frank, Thursky, Karin, De Abreu Lourenco, Richard, Slavin, Monica A., Babl, Franz E., Mechinaud, Francoise, Phillips, Robert, Tapp, Heather, Padhye, Bhavna, Zeigler, David, Clark, Julia